全球酵素市場：策略分析與未來預測

Abstract

This report analyzes the worldwide markets for Specialty Enzymes in Millions of US$. The specific product segments analyzed are Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 44 companies including many key and niche players worldwide such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Operational Model of Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes, Seravac Biotech (Pty) Ltd, Specialty Enzymes and Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability And Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions And Scope Of Study
• Specialty Medical Enzymes
• Polymerases
• Nucleases
• Other Specialty Enzymes
• Pharmaceuticals/Diagnostic
• Research/Biotechnology

II. EXECUTIVE SUMMARY

1. Introduction

2. Global Market Overview

3. Enzymes- A Review

• Definition
• Introduction
• Advantages of Enzymes Compared to Chemical Catalysts
• Table 1: Enzymes Market Worldwide (2005 & 2006): Market Share of Leading Players- Novozymes, Genencol, DSM, BASF and Others (includes corresponding Graph/Chart)
• A Brief History

4. Specialty Enzymes: An Overview

• Analysis of Product Segments
• Specialty Medical Enzymes
• Polymerases
• Nucleases
• Other Specialty Enzymes

5. Analysis of the End-Use Markets

• Pharmaceuticals & Diagnostics
• Research/Biotechnology
• Other End Use Markets

6. Technology Trends

• Protein Engineering Technology
• Specialty Enzymes in Industrial Uses
• Enzyme Technology in Pig Industry

7. Product Innovations/Introductions

• MARDI Develops Taq DNA Polymerase
• Stratagene Corporation Commercializes DNA Polymerases
• Takara Bio Launches PrimeSTAR HS DNA Polymerase
• Verdia and Pioneer Hi-Bred International Develops Glyphosate-Resistant Crop Trait
• Novozymes Creates Lipase Enzyme

8. Recent Industry Activity

• Inverness Medical Innovations Acquires BBI Holdings Plc
• Helix Biopharma Enters into a Contract with KBI Biopharma
• Verenium Enters into Agreement with Bunge Oils
• BBI Holdings Acquires Theratase Plc
• Danisco to Acquire Stake in South African Firm
• Affymetrix to Buy USB Corporation
• Diversa Merges with Celunol to Form Verenium Corporation
• Diversa Collaborates with BASF
• Codexis Expands Collaboration with Royal Dutch Shell to Develop Super Enzymes
• Diversa Enters into a Deal with Syngenta to Develop Enzymes
• Genencor Begins Operation at New China Site and Introduces a New Detergent Enzyme
• Verenium Receives $4.6 million For Enzyme Development
• Biocon Divests its Enzymes Business to Novozymes
• Solexa Signs Agreement with New England Biolabs
• Danisco Takes Over Genencor
• IBEX Technologies Inks Agreement with Cape Cod and Prozyme

9. Focus on Select Players Worldwide

• Advanced Enzymes Technologies Limited (India)
• Amano Enzyme Inc. (Japan)
• Aureozyme Inc. (USA)
• Biocon Ltd. (India)
• Operational Model of Biocon
• Biozyme Laboratories (UK)
• Danisco (Denmark)
• Genencor (USA)
• Kinetic Biosystems, Inc. (USA)
• Maxygen Inc (USA)
• Codexis Inc. (USA)
• Novozymes (Denmark)
• Seravac Biotech (Pty) Ltd (South Africa)
• Specialty Enzymes and Biochemicals Co. (USA)
• Verenium Corporation (USA)

10. Global Market Perspective

• Table 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 3: World Long-term Projections for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 4: World 10-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 5: World Recent Past, Current & Future Analysis for Specialty Medical Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 6: World Long-term Projections for Specialty Medical Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 7: World 10-Year Perspective for Specialty Medical Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 8: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 9: World Long-term Projections for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 10: World 10-Year Perspective for Polymerases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 11: World Recent Past, Current & Future Analysis for Nucleases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 12: World Long-term Projections for Nucleases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 13: World 10-Year Perspective for Nucleases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 14: World Recent Past, Current & Future Analysis for Other Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 15: World Long-term Projections for Other Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 16: World 10-Year Perspective for Other Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 17: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 18: World Long-term Projections for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 19: World 10-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 20: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 21: World Long-term Projections for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 22: World 10-Year Perspective for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 23: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 24: World Long-term Projections for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 25: World 10-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Market Dynamics
  • Specialty Enzymes Market is Projected to Rise 7% Annually
  • Specialty Enzymes Form the Leading Enzymes Segment
  • Pharmaceuticals and Diagnostics Continue to be the Largest Market
  • Specialty Medical Enzymes in a Myriad of Novel Applications
  • Market for Enzymes in Biotechnology
  • Product Launch
  • Strategic Corporate Developments ...
  • Select Players
  • Aureozyme Inc.
  • Genencor.
  • Kinetic Biosystems, Inc.
  • Maxygen Inc
  • Codexis Inc.
  • Specialty Enzymes and Biochemicals Co.
  • Verenium Corporation
• B. Market Analytics
  • Table 26: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 27: US Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 28: US 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 29: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 30: US Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 31: US 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2. Canada

• A. Market Analysis
  • Strategic Corporate Development
• B. Market Analytics
  • Table 32: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
  • Table 33: Canadian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 34: Canadian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 35: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 36: Canadian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 37: Canadian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Japan

• A. Market Analysis
  • Product Launch
  • Amano Enzyme Inc. - A Major Player
• B. Market Analytics
  • Table 38: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 39: Japanese Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 40: Japanese 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 41: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 42: Japanese Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 43: Japanese 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4. Europe

• Market Analysis
• Table 44: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 45: European Long-term Projections for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 46: European 10-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 47: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 48: European Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 49: European 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 50: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 51: European Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 52: European 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4a. France

• Market Analysis
• Table 53: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 54: French Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 55: French 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 56: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 57: French Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 58: French 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4b. Germany

• Market Analysis
• Table 59: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 60: German Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 61: German 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 62: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 63: German Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 64: German 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4c. Italy

• Market Analysis
• Table 65: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 66: Italian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 67: Italian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 68: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 69: Italian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 70: Italian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4d. The United Kingdom

• A. Market Analysis
  • Biozyme Laboratories Limited - A Major Player
• B. Market Analytics
  • Table 71: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 72: UK Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 73: UK 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 74: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 75: UK Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 76: UK 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4e. Spain

• Market Analysis
• Table 77: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 78: Spanish Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 79: Spanish 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012(includes corresponding Graph/Chart)
• Table 80: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
• Table 81: Spanish Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 82: Spanish 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4f. Russia

• Market Analysis
• Table 83: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 84: Russian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 85: Russian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 86: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 87: Russian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 88: Russian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4g. Rest of Europe

• A. Market Analysis
  • Strategic Corporate Development
  • Select Players
  • Danisco (Denmark)
  • Novozymes (Denmark)
• B. Market Analytics
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 90: Rest of Europe Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 91: Rest of Europe 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 93: Rest of Europe Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 94: Rest of Europe 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

5. Asia-Pacific

• A. Market Analysis
  • Enzyme Market in China
  • Product Launch
  • Strategic Corporate Development
  • Select Players
  • Advanced Enzymes Technologies Limited (India)
  • Biocon Ltd. (India)
• B. Market Analytics
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 96: Asia-Pacific Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 97: Asia-Pacific 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
  • Table 99: Asia-Pacific Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
  • Table 100: Asia-Pacific 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

6. The Middle East

• Market Analysis
• Table 101: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 102: Middle East Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 103: Middle East 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 104: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
• Table 105: Middle East Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 106: Middle East 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

7. Latin America

• Market Analysis
• Table 107: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 108: Latin American Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 109: Latin American 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)
• Table 110: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
• Table 111: Latin American Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
• Table 112: Latin American 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)